Michael R. Pisano
Plus aucun poste en cours
Profil
Michael R.
Pisano is Chief Scientific Officer of NextGen Sciences Ltd.
He was a Group Leader of Proteomics and Protein Production of Rhone-Poulenc Rorer Pharmaceuticals.
Mr. Pisano was the Head of Protein Sciences of Aventis Pharmaceuticals.
He was Vice-President of Proteomic R&D for Genomic Solutions, Inc. In addition, Dr. Pisano is one of the Founders of PRS (2001).
Anciens postes connus de Michael R. Pisano
| Sociétés | Poste | Fin |
|---|---|---|
NextGen Group Plc
 NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | President | - |
NextGen Sciences Ltd.
 NextGen Sciences Ltd. BiotechnologyHealth Technology NextGen Sciences Ltd. provides technologies and reagents for molecular biology and protein research. Its advanced products automate and simplify complex research techniques, saving time and resources, improving results, and accelerating discovery. The company was founded on January 28, 2000 by Kevin Auton and David Wigley and is headquartered in Huntingdon, the United Kingdom. | Directeur Général | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NextGen Sciences Ltd.
NextGen Sciences Ltd. BiotechnologyHealth Technology NextGen Sciences Ltd. provides technologies and reagents for molecular biology and protein research. Its advanced products automate and simplify complex research techniques, saving time and resources, improving results, and accelerating discovery. The company was founded on January 28, 2000 by Kevin Auton and David Wigley and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
NextGen Group Plc
NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Commercial Services |
